EP2307457
Stable and soluble antibodies inhibiting TNF
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
25.6.2009EP published:
13.6.2018EP application number:
09768692.7
EP translation filed:
26.9.2018Grant published:
15.10.2018EPO information:
European Patent Register
Max expiry date:
24.6.2029Expiry date:
24.6.2026Next due date:
30.6.2026
Title:
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF
Timeline
Today
25.6.2009EP application
13.6.2018EP Publication
26.9.2018Translation submitted
15.10.2018Registration published
24.6.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BORRAS, LeonardoAddress:
Schlieren, CH
Name:
GUNDE, TeaAddress:
Zürich, CH
Name:
URECH, DavidAddress:
Hombrechtikon, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
75640 PDate:
25.6.2008Country:
US
Number:
75697 PDate:
25.6.2008Country:
US
Number:
75692 PDate:
25.6.2008Country:
US
Number:
75956 PDate:
26.6.2008Country:
US
Number:
155041 PDate:
24.2.2009Country:
US
Classification
Categories:
C07K 16/24, A61K 39/395, C12N 15/13
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 17.9.2018
Expires: 24.6.2019
Payer: Árnason Faktor
Number: 11
Paid: 23.5.2019
Expires: 24.6.2020
Payer: Árnason Faktor
Number: 12
Paid: 26.5.2020
Expires: 24.6.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 25.5.2021
Expires: 24.6.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.5.2022
Expires: 24.6.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.5.2023
Expires: 24.6.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 23.5.2024
Expires: 24.6.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.6.2025
Expires: 24.6.2026
Payer: Árnason Faktor ehf.